ArticleJournal of translational medicine2011

A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases.

Chong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.